SlidesetHIVINTEREST 2022Accelerating HIV Epidemic Control in Benue State, Nigeria, 2019-2021The APIN Program Experience - Mikhail ObajeView Slideset
SlidesetHIVINTEREST 2022What Rx to Start, PH Approach vs Individualized Therapy - François Venter, MD, FCP, PhDView Slideset
SlidesetHIVINTEREST 2022Une Entrée Difficile Dans la Sexualité Pour les Adolescentes Séropositives au Sénégal, Entre Normes Sociales et VIH - Maimouna DiopView Slideset
SlidesetHIVINTEREST 2022Supporting Self-Management in Adolescents to Be Resilient and Thrivean Intervention Development Study - Talitha CrowleyView Slideset
SlidesetHIVINTEREST 2022Switching When Detectable with-out Resistance Testing - Nickolas Paton, MD, FRCPView Slideset
SlidesetHIVINTEREST 2022Shifting from 3-Multimonth Prescribing (3MMP) to 6-Multimonth Prescribing (6MMP) Was Associated with Non-Inferior Outcomes for Adults on Antiretroviral Therapy in Rwanda - Brian KwizeraView Slideset
SlidesetHIVINTEREST 2022Risks and Vulnerabilities Among Adolescent Girls and Young Women Accessing HIV Prevention Services at DREAMS Centers in Zambia - Namukale NanyangweView Slideset
SlidesetHIVINTEREST 2022Risk Factors for Frailty in a Geriatric Cohort on Long Term Antiretroviral Treatment in Uganda - Phoebe MbabaziView Slideset
SlidesetHIVINTEREST 2022Progress in Treatment for Viral Hepatitis - What are the Implications for Treatment - Jürgen Rockstroh, MDView Slideset
SlidesetHIVINTEREST 2022Leaving No One behind The Impact of Kindergarten ART clinic on HIV Treatment Outcomes Among Children Enrolled in Kindergarten HIV Program at Lighthouse HIV Care Facilities - Ackim SankhaniView Slideset
SlidesetHIVINTEREST 2022HIV, Non-Communicable Disease, and Aging - Barbara Castelnuovo, MD, PhDView Slideset
SlidesetHIVINTEREST 2022Dolutegravir-Based Regimen Ensures High Virological Success Despite Prior Exposure to Efavirenz-Based First-Line ART a Comparative Study in Cameroon - Ezechiel Ngoufack Jagni SemengueView Slideset